Highlands Oncology Group Physician Will Have New Abstracts Released at International Congress of the Society for Melanoma Research in Zurich.
Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), will be conducting a clinical trial testing treatments for patients with melanoma carrying the NRAS mutation
Texas becomes fifth state to enact an under-18 tanning ban
Return reflects challenges in treatment of solid tumor cancers and the need for better therapeutic delivery.
Nevada becomes fourth state to enact an under-18 tanning ban
The inaugural AIM for the CURE Melanoma Walk in Fullerton will raise funds to support research for the CURE of melanoma on May 12
Accurate knowledge is key for prevention, detection and also treatment.
San Diego-based OncoSec Medical Inc. among those who are looking at novel approaches.
Melanoma, like many other modern diseases, had previously been considered an age related condition.
Health Discovery Corporation, developers of MelApp, reports great adoption among consumers with nearly 5,000 downloads across 48 countries in just its first 2 months. Pleased with the interest, the company will launch MelApp for Android in October.
Jeffrey S. Weber, MD, PhD, of the H. Lee Moffitt Cancer Center leads a 1-day conference to provide clinicians with an update on the science of melanoma, pertinent clinical trial information, investigational agents, and their unusual adverse effects.
Christos Prevezas Software released a new dermatology software application that enables dermatologists
to make a body mole mapping of their patients , monitor their skin lesions and assist in the diagnosis of melanoma and other types of cancer.
Today marks a major advance in the fight against skin cancer, as the U.S. Food and Drug Administration (FDA) approved a new immune-based therapy for the treatment of melanoma, the leading cause of death from skin cancer.
IMER, an oncology continuing education company, will offer a free live webcast on advanced melanoma. This unique event is part of the 6 symposia series IMER will offer during the ONS 36th Annual Congress in Boston.
Immunotherapy made a giant leap forward this weekend with the release of clinical trial results of BMS's ipilimumab. The results indicate that ipilimumab significantly improved the survival of patients with late stage melanoma.
With May being Skin Cancer Awareness Month, it is good time for golfers to learn how to protect themselves in the sun and to schedule an exam to see what sun damage they may have incurred.